Treatment of Lupus Nephritis with Abatacept: The Abatacept and Cyclophosphamide Combination Efficacy and Safety Study

OBJECTIVE: To assess the efficacy and safety of a 24-week course of abatacept in the treatment of active lupus nephritis. An additional exploratory objective was to assess the potential of abatacept to induce ‘clinical tolerance’, defined as sustained clinical quiescence of lupus nephritis after dis...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Arthritis Rheumatol
Κύριοι συγγραφείς: Askanase, Anca, Byron, Margie, Keyes-Elstein, Lynette, Cagnoli, Patricia, McCune, W. Joseph, Chatham, W. Winn, Contreras, Gabriel, Daikh, David, Dall'Era, Maria, Wofsy, David, Davidson, Anne, Diamond, Betty, Mackay, Meggan, Ding, Linna, Gao, Wendy, Dooley, Mary Anne, Fragoso-Loyo, Hilda, Sanchez-Guerrero, Jorge, Karp, David, Olsen, Nancy, Jolly, Meenakshi, Kalunian, Kenneth, Kamen, Diane, Lee, Iris, Levesque, Marc C., Lim, S. Sam, Ramos-Remus, Cesar, Rovin, Brad, Sayre, Peter, Smilek, Dawn, Tosta, Patti, Utset, Tammy, Venuturupalli, Swamy, Winchester, Robert
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2014
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4528976/
https://ncbi.nlm.nih.gov/pubmed/25403681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.38790
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια